Clinical Trial Update: 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma [NA]

View source ↗

Summary

A completed clinical trial evaluated 18F-FDG and 68Ga-FAPI PET/CT imaging in lung adenocarcinoma. The sponsor is The First Affiliated Hospital of Xiamen Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Lung Adenocarcinoma, 18F-FDG | NA | Status: COMPLETED